Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids

Objective. Ciclosporin and MTX are used in idiopathic inflammatory myopathies (DM and PM) when patients incompletely respond to glucocorticoids. Their effectiveness is unproved in randomized controlled trials (RCTs). We evaluated their benefits in a placebo-controlled factorial RCT. Methods. A 56-we...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Fowzia, Choy, Ernest, Gordon, Patrick, Doré, Caroline J., Hakim, Alan, Kitas, George, Isenberg, David, Griffiths, Bridget, Lecky, Bryan, Chakravarty, Kuntal, Winer, John, Danko, Katalin, Cooper, Robert G., White-Alao, Beverley, Scott, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476843/
https://www.ncbi.nlm.nih.gov/pubmed/25433040
http://dx.doi.org/10.1093/rheumatology/keu442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476843/
https://www.ncbi.nlm.nih.gov/pubmed/25433040
http://dx.doi.org/10.1093/rheumatology/keu442

Ejemplares similares